Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Related structures:
AlphaFold database: E9APN3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 217 | 221 | PF00656 | 0.464 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.452 |
CLV_NRD_NRD_1 | 206 | 208 | PF00675 | 0.427 |
CLV_NRD_NRD_1 | 285 | 287 | PF00675 | 0.719 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.426 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.555 |
CLV_PCSK_PC1ET2_1 | 301 | 303 | PF00082 | 0.555 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.470 |
CLV_PCSK_SKI1_1 | 166 | 170 | PF00082 | 0.539 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.426 |
DEG_APCC_DBOX_1 | 19 | 27 | PF00400 | 0.476 |
DOC_CYCLIN_yCln2_LP_2 | 236 | 242 | PF00134 | 0.286 |
DOC_MAPK_gen_1 | 228 | 238 | PF00069 | 0.403 |
DOC_MAPK_gen_1 | 48 | 57 | PF00069 | 0.400 |
DOC_MAPK_MEF2A_6 | 48 | 57 | PF00069 | 0.380 |
DOC_PP1_RVXF_1 | 258 | 264 | PF00149 | 0.483 |
DOC_PP1_RVXF_1 | 46 | 52 | PF00149 | 0.528 |
DOC_PP2B_LxvP_1 | 236 | 239 | PF13499 | 0.330 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.400 |
DOC_USP7_MATH_1 | 98 | 102 | PF00917 | 0.542 |
DOC_USP7_UBL2_3 | 154 | 158 | PF12436 | 0.299 |
DOC_WW_Pin1_4 | 158 | 163 | PF00397 | 0.414 |
LIG_14-3-3_CanoR_1 | 260 | 264 | PF00244 | 0.459 |
LIG_14-3-3_CanoR_1 | 90 | 98 | PF00244 | 0.444 |
LIG_BIR_III_4 | 16 | 20 | PF00653 | 0.415 |
LIG_BRCT_BRCA1_1 | 164 | 168 | PF00533 | 0.378 |
LIG_FHA_1 | 122 | 128 | PF00498 | 0.436 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.450 |
LIG_FHA_1 | 171 | 177 | PF00498 | 0.382 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.524 |
LIG_FHA_1 | 260 | 266 | PF00498 | 0.424 |
LIG_FHA_1 | 293 | 299 | PF00498 | 0.576 |
LIG_FHA_2 | 273 | 279 | PF00498 | 0.537 |
LIG_FHA_2 | 94 | 100 | PF00498 | 0.402 |
LIG_LIR_Apic_2 | 147 | 153 | PF02991 | 0.400 |
LIG_LIR_Gen_1 | 123 | 131 | PF02991 | 0.352 |
LIG_LIR_Gen_1 | 199 | 205 | PF02991 | 0.436 |
LIG_LIR_Gen_1 | 44 | 53 | PF02991 | 0.473 |
LIG_LIR_LC3C_4 | 172 | 176 | PF02991 | 0.259 |
LIG_LIR_Nem_3 | 123 | 129 | PF02991 | 0.351 |
LIG_LIR_Nem_3 | 185 | 190 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 199 | 203 | PF02991 | 0.372 |
LIG_LIR_Nem_3 | 27 | 32 | PF02991 | 0.452 |
LIG_LIR_Nem_3 | 44 | 49 | PF02991 | 0.418 |
LIG_REV1ctd_RIR_1 | 261 | 268 | PF16727 | 0.265 |
LIG_SH2_CRK | 187 | 191 | PF00017 | 0.361 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.457 |
LIG_SH2_NCK_1 | 305 | 309 | PF00017 | 0.447 |
LIG_SH2_STAP1 | 32 | 36 | PF00017 | 0.295 |
LIG_SH2_STAP1 | 77 | 81 | PF00017 | 0.371 |
LIG_SH2_STAT5 | 187 | 190 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.456 |
LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.379 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.350 |
LIG_SH3_1 | 69 | 75 | PF00018 | 0.470 |
LIG_SH3_3 | 69 | 75 | PF00018 | 0.450 |
LIG_SUMO_SIM_anti_2 | 215 | 222 | PF11976 | 0.440 |
MOD_CK1_1 | 144 | 150 | PF00069 | 0.495 |
MOD_CK1_1 | 161 | 167 | PF00069 | 0.266 |
MOD_CK2_1 | 286 | 292 | PF00069 | 0.676 |
MOD_CK2_1 | 81 | 87 | PF00069 | 0.479 |
MOD_CK2_1 | 93 | 99 | PF00069 | 0.499 |
MOD_Cter_Amidation | 18 | 21 | PF01082 | 0.470 |
MOD_Cter_Amidation | 284 | 287 | PF01082 | 0.506 |
MOD_GlcNHglycan | 16 | 20 | PF01048 | 0.535 |
MOD_GlcNHglycan | 220 | 224 | PF01048 | 0.507 |
MOD_GlcNHglycan | 252 | 255 | PF01048 | 0.515 |
MOD_GlcNHglycan | 280 | 283 | PF01048 | 0.576 |
MOD_GlcNHglycan | 288 | 291 | PF01048 | 0.590 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.438 |
MOD_GSK3_1 | 158 | 165 | PF00069 | 0.357 |
MOD_GSK3_1 | 259 | 266 | PF00069 | 0.323 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.727 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.394 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.447 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.538 |
MOD_N-GLC_1 | 144 | 149 | PF02516 | 0.465 |
MOD_N-GLC_1 | 158 | 163 | PF02516 | 0.387 |
MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.452 |
MOD_N-GLC_2 | 108 | 110 | PF02516 | 0.400 |
MOD_NEK2_1 | 141 | 146 | PF00069 | 0.503 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.519 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.577 |
MOD_NEK2_1 | 272 | 277 | PF00069 | 0.621 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.449 |
MOD_PIKK_1 | 27 | 33 | PF00454 | 0.570 |
MOD_PKA_1 | 286 | 292 | PF00069 | 0.707 |
MOD_PKA_2 | 148 | 154 | PF00069 | 0.398 |
MOD_PKA_2 | 259 | 265 | PF00069 | 0.300 |
MOD_Plk_1 | 121 | 127 | PF00069 | 0.456 |
MOD_Plk_1 | 132 | 138 | PF00069 | 0.370 |
MOD_Plk_1 | 144 | 150 | PF00069 | 0.347 |
MOD_Plk_1 | 292 | 298 | PF00069 | 0.686 |
MOD_Plk_1 | 34 | 40 | PF00069 | 0.442 |
MOD_Plk_1 | 41 | 47 | PF00069 | 0.455 |
MOD_Plk_2-3 | 292 | 298 | PF00069 | 0.696 |
MOD_Plk_4 | 121 | 127 | PF00069 | 0.433 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.414 |
MOD_Plk_4 | 170 | 176 | PF00069 | 0.461 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.483 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.388 |
MOD_ProDKin_1 | 158 | 164 | PF00069 | 0.409 |
MOD_SUMO_for_1 | 153 | 156 | PF00179 | 0.434 |
MOD_SUMO_rev_2 | 111 | 118 | PF00179 | 0.481 |
MOD_SUMO_rev_2 | 151 | 160 | PF00179 | 0.290 |
TRG_ENDOCYTIC_2 | 187 | 190 | PF00928 | 0.593 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.475 |
TRG_ENDOCYTIC_2 | 226 | 229 | PF00928 | 0.560 |
TRG_ER_diArg_1 | 20 | 22 | PF00400 | 0.452 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0V1 | Leptomonas seymouri | 55% | 100% |
A0A0S4KDQ4 | Bodo saltans | 43% | 100% |
A0A1X0NQ77 | Trypanosomatidae | 45% | 99% |
A0A381MFS8 | Leishmania infantum | 73% | 100% |
A0A3Q8I9T1 | Leishmania donovani | 81% | 100% |
A0A3R7N2S2 | Trypanosoma rangeli | 44% | 97% |
A0A3S7WSX7 | Leishmania donovani | 73% | 100% |
A4H7J8 | Leishmania braziliensis | 54% | 100% |
C9ZT43 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 94% |
E9AGK8 | Leishmania infantum | 79% | 100% |
E9APN2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 86% | 100% |
E9APN4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 84% | 100% |
Q4QFU5 | Leishmania major | 77% | 100% |
Q4QFU6 | Leishmania major | 73% | 100% |
V5BD72 | Trypanosoma cruzi | 43% | 97% |